Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » InformedDNA, WCG Aim to Fill Growing Need for Genetics Expertise in Clinical Trial Management

InformedDNA, WCG Aim to Fill Growing Need for Genetics Expertise in Clinical Trial Management

Jun 27, 2018
|
Molika Ashford
Premium

NEW YORK (GenomeWeb) – InformedDNA and WIRB-Copernicus Group (WCG) announced this week that they have teamed up to create what they call a "Center for Genetics and Precision Medicine in Clinical Trials," offering consulting and management services for precision medicine drug development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Working Out the Effect

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Increased Genetic Privacy in Florida

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

Attention-Grabbing in Two Ways

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

Nature Papers Describe CRISPR Plant Editing Methods, DNA-PAINT Improvements, More

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.

What's Popular?

In Business News

  1. Cancer AI Startup Nucleai Raises $6.5M in Series A

  2. Quidel Preliminary Q2 Revenues Jump More Than 86 Percent

  3. Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

  4. Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

  5. Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.